{
    "xml": "<topic id=\"PHP1252\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/aliskiren\" basename=\"aliskiren\" title=\"ALISKIREN\">\n<title>ALISKIREN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1099\" namespace=\"/interactions/list-of-drug-interactions/aliskiren\">Aliskiren</xref>\n</p>\n<data name=\"vtmid\">427002003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_389989988\" title=\"Renin inhibitors\">Renin inhibitors</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP36752\" outputclass=\"drugAction\" rev=\"1.5\" parent=\"/drugs/aliskiren\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Renin inhibitors inhibit renin directly; renin converts angiotensinogen to angiotensin &#8544;.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36736\" outputclass=\"indicationsAndDose\" rev=\"1.22\" parent=\"/drugs/aliskiren\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Essential hypertension either alone or in combination with other antihypertensives</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>150&#8239;mg once daily, increased if necessary to 300&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36760\" outputclass=\"contraindications\" rev=\"1.21\" parent=\"/drugs/aliskiren\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Concomitant treatment with an ACE inhibitor or an angiotensin-II receptor antagonist in patients with an eGFR less than 60&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup>\n</ph>; <ph outputclass=\"contraindication\">concomitant treatment with an ACE inhibitor or an angiotensin-II receptor antagonist in patients with diabetes mellitus</ph>; <ph outputclass=\"contraindication\">hereditary angioedema</ph>; <ph outputclass=\"contraindication\">idiopathic angioedema</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36770\" outputclass=\"cautions\" rev=\"1.32\" parent=\"/drugs/aliskiren\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Combination treatment with an ACE inhibitor</ph>; <ph outputclass=\"caution\">combination treatment with an angiotensin-II receptor antagonist</ph>; <ph outputclass=\"caution\">concomitant use of diuretics (first doses may cause hypotension&#8212;initiate with care)</ph>; <ph outputclass=\"caution\">history of angioedema</ph>; <ph outputclass=\"caution\">moderate to severe congestive heart failure</ph>; <ph outputclass=\"caution\">patients at risk of renal impairment</ph>; <ph outputclass=\"caution\">salt depletion (first doses may cause hypotension&#8212;initiate with care)</ph>; <ph outputclass=\"caution\">volume depletion (first doses may cause hypotension&#8212;initiate with care)</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Concomitant use of drugs affecting the renin-angiotensin system</p>\n<p>Combination therapy with two drugs affecting the renin-angiotensin system (ACE inhibitors, angiotensin-II receptor antagonists, and aliskiren) is not recommended due to an increased risk of hyperkalaemia, hypotension, and renal impairment, compared to use of a single drug. Patients with diabetic nephropathy are particularly susceptible to developing hyperkalaemia and should not be given an ACE inhibitor with an angiotensin-II receptor antagonist. There is some evidence that the benefits of combination use of an ACE inhibitor with candesartan or valsartan may outweigh the risks in selected patients with heart failure for whom other treatments are unsuitable, however, the concomitant use of this combination, together with an aldosterone antagonist or a potassium-sparing diuretic is not recommended. For patients currently taking combination therapy, the need for continued combined therapy should be reviewed. If combination therapy is considered essential, it should be carried out under specialist supervision, with close monitoring of blood pressure, renal function, and electrolytes (particularly potassium); monitoring should be considered at the start of treatment, then monthly, and also after any change in dose or during intercurrent illness.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36735\" outputclass=\"interactions\" rev=\"1.4\" parent=\"/drugs/aliskiren\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (aliskiren).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36725\" outputclass=\"sideEffects\" rev=\"1.14\" parent=\"/drugs/aliskiren\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arthralgia</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">hyperkalaemia</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Acute renal failure (reversible on discontinuation of treatment)</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">palpitation</ph>; <ph outputclass=\"sideEffect\">peripheral oedema</ph>; <ph outputclass=\"sideEffect\">cough</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">toxic epidermal necrolysis</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaemia</ph>; <ph outputclass=\"sideEffect\">angioedema</ph>; <ph outputclass=\"sideEffect\">erythema</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Liver disorders</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">vertigo</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p>If diarrhoea severe or persistent discontinue treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36733\" outputclass=\"pregnancy\" parent=\"/drugs/aliskiren\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available; other drugs acting on the renin-angiotensin system have been associated with fetal malformations and neonatal death.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36776\" outputclass=\"breastFeeding\" parent=\"/drugs/aliskiren\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Present in milk in <i>animal</i> studies&#8212;manufacturer advises avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36728\" outputclass=\"renalImpairment\" parent=\"/drugs/aliskiren\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid if eGFR is less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>&#8212; no information available.</p>\n<p>Use with caution in renal artery stenosis&#8212;no information available.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInRenalImpairment\">\n<sectiondiv>\n<p>Monitor plasma-potassium concentration in renal impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36719\" outputclass=\"monitoringRequirements\" parent=\"/drugs/aliskiren\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor patients with a history of angioedema closely during treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36714\" outputclass=\"nationalFunding\" rev=\"1.5\" parent=\"/drugs/aliskiren\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium </i>has advised (January 2010) that aliskiren (<i>Rasilez</i>\n<tm tmtype=\"reg\"/>) is <b>not</b> recommended for use within NHS Scotland.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1252-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/aliskiren\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75134\" title=\"Tablet\" namespace=\"/drugs/aliskiren/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78146\" namespace=\"/treatment-summaries/drugs-affecting-the-renin-angiotensin-system\" title=\"Drugs affecting the renin-angiotensin system\" count=\"1\" rel=\"backlink\">Drugs affecting the renin-angiotensin system</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1099\" namespace=\"/interactions/list-of-drug-interactions/aliskiren\" title=\"Aliskiren\" count=\"1\" rel=\"link\">Aliskiren</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75134\" namespace=\"/drugs/aliskiren/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP1252",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/aliskiren",
    "basename": "aliskiren",
    "title": "ALISKIREN",
    "interactants": [
        {
            "id": "bnf_int_1099",
            "label": "Aliskiren"
        }
    ],
    "vtmid": "427002003",
    "drugClassification": [
        "Renin inhibitors"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Renin inhibitors inhibit renin directly; renin converts angiotensinogen to angiotensin &#8544;.",
                "html": "<p>Renin inhibitors inhibit renin directly; renin converts angiotensinogen to angiotensin &#8544;.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Essential hypertension either alone or in combination with other antihypertensives",
                        "html": "Essential hypertension either alone or in combination with other antihypertensives"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "150 mg once daily, increased if necessary to 300 mg once daily.",
                        "html": "<p>150&#8239;mg once daily, increased if necessary to 300&#8239;mg once daily.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Concomitant treatment with an ACE inhibitor or an angiotensin-II receptor antagonist in patients with an eGFR less than 60 mL/minute/ 1.73 m2",
                "html": "Concomitant treatment with an ACE inhibitor or an angiotensin-II receptor antagonist in patients with an eGFR less than 60&#8239;mL/minute/ 1.73&#8239;m<sup>2</sup>"
            },
            {
                "type": "contraindications",
                "textContent": "concomitant treatment with an ACE inhibitor or an angiotensin-II receptor antagonist in patients with diabetes mellitus",
                "html": "concomitant treatment with an ACE inhibitor or an angiotensin-II receptor antagonist in patients with diabetes mellitus"
            },
            {
                "type": "contraindications",
                "textContent": "hereditary angioedema",
                "html": "hereditary angioedema"
            },
            {
                "type": "contraindications",
                "textContent": "idiopathic angioedema",
                "html": "idiopathic angioedema"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Combination treatment with an ACE inhibitor",
                "html": "Combination treatment with an ACE inhibitor"
            },
            {
                "type": "cautions",
                "textContent": "combination treatment with an angiotensin-II receptor antagonist",
                "html": "combination treatment with an angiotensin-II receptor antagonist"
            },
            {
                "type": "cautions",
                "textContent": "concomitant use of diuretics (first doses may cause hypotension&#8212;initiate with care)",
                "html": "concomitant use of diuretics (first doses may cause hypotension&#8212;initiate with care)"
            },
            {
                "type": "cautions",
                "textContent": "history of angioedema",
                "html": "history of angioedema"
            },
            {
                "type": "cautions",
                "textContent": "moderate to severe congestive heart failure",
                "html": "moderate to severe congestive heart failure"
            },
            {
                "type": "cautions",
                "textContent": "patients at risk of renal impairment",
                "html": "patients at risk of renal impairment"
            },
            {
                "type": "cautions",
                "textContent": "salt depletion (first doses may cause hypotension&#8212;initiate with care)",
                "html": "salt depletion (first doses may cause hypotension&#8212;initiate with care)"
            },
            {
                "type": "cautions",
                "textContent": "volume depletion (first doses may cause hypotension&#8212;initiate with care)",
                "html": "volume depletion (first doses may cause hypotension&#8212;initiate with care)"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Concomitant use of drugs affecting the renin-angiotensin system",
                "textContent": "Combination therapy with two drugs affecting the renin-angiotensin system (ACE inhibitors, angiotensin-II receptor antagonists, and aliskiren) is not recommended due to an increased risk of hyperkalaemia, hypotension, and renal impairment, compared to use of a single drug. Patients with diabetic nephropathy are particularly susceptible to developing hyperkalaemia and should not be given an ACE inhibitor with an angiotensin-II receptor antagonist. There is some evidence that the benefits of combination use of an ACE inhibitor with candesartan or valsartan may outweigh the risks in selected patients with heart failure for whom other treatments are unsuitable, however, the concomitant use of this combination, together with an aldosterone antagonist or a potassium-sparing diuretic is not recommended. For patients currently taking combination therapy, the need for continued combined therapy should be reviewed. If combination therapy is considered essential, it should be carried out under specialist supervision, with close monitoring of blood pressure, renal function, and electrolytes (particularly potassium); monitoring should be considered at the start of treatment, then monthly, and also after any change in dose or during intercurrent illness.",
                "html": "<p>Combination therapy with two drugs affecting the renin-angiotensin system (ACE inhibitors, angiotensin-II receptor antagonists, and aliskiren) is not recommended due to an increased risk of hyperkalaemia, hypotension, and renal impairment, compared to use of a single drug. Patients with diabetic nephropathy are particularly susceptible to developing hyperkalaemia and should not be given an ACE inhibitor with an angiotensin-II receptor antagonist. There is some evidence that the benefits of combination use of an ACE inhibitor with candesartan or valsartan may outweigh the risks in selected patients with heart failure for whom other treatments are unsuitable, however, the concomitant use of this combination, together with an aldosterone antagonist or a potassium-sparing diuretic is not recommended. For patients currently taking combination therapy, the need for continued combined therapy should be reviewed. If combination therapy is considered essential, it should be carried out under specialist supervision, with close monitoring of blood pressure, renal function, and electrolytes (particularly potassium); monitoring should be considered at the start of treatment, then monthly, and also after any change in dose or during intercurrent illness.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (aliskiren).",
                "html": "<p>Appendix 1 (aliskiren).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Arthralgia",
                        "html": "Arthralgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hyperkalaemia",
                        "html": "hyperkalaemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Acute renal failure (reversible on discontinuation of treatment)",
                        "html": "Acute renal failure (reversible on discontinuation of treatment)",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "palpitation",
                        "html": "palpitation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "peripheral oedema",
                        "html": "peripheral oedema",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "cough",
                        "html": "cough",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "toxic epidermal necrolysis",
                        "html": "toxic epidermal necrolysis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Anaemia",
                        "html": "Anaemia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "angioedema",
                        "html": "angioedema",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "erythema",
                        "html": "erythema",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Liver disorders",
                        "html": "Liver disorders",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vertigo",
                        "html": "vertigo",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "textContent": "If diarrhoea severe or persistent discontinue treatment.",
                "html": "<p>If diarrhoea severe or persistent discontinue treatment.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available; other drugs acting on the renin-angiotensin system have been associated with fetal malformations and neonatal death.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available; other drugs acting on the renin-angiotensin system have been associated with fetal malformations and neonatal death.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Present in milk in animal studies&#8212;manufacturer advises avoid.",
                "html": "<p>Present in milk in <i>animal</i> studies&#8212;manufacturer advises avoid.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid if eGFR is less than 30 mL/minute/1.73 m2&#8212; no information available.\n\nUse with caution in renal artery stenosis&#8212;no information available.",
                "html": "<p>Avoid if eGFR is less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>&#8212; no information available.</p><p>Use with caution in renal artery stenosis&#8212;no information available.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "Monitor plasma-potassium concentration in renal impairment.",
                "html": "<p>Monitor plasma-potassium concentration in renal impairment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor patients with a history of angioedema closely during treatment.",
                "html": "<p>Monitor patients with a history of angioedema closely during treatment.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (January 2010) that aliskiren (Rasilez ) is not recommended for use within NHS Scotland.",
                "html": "<p>The <i>Scottish Medicines Consortium </i>has advised (January 2010) that aliskiren (<i>Rasilez</i> <tm tmtype=\"reg\"/>) is <b>not</b> recommended for use within NHS Scotland.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75134",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78146",
                "label": "Drugs affecting the renin-angiotensin system",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1099",
                "label": "Aliskiren",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75134",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}